Berger Mark Stanley 4
4 · Genprex, Inc. · Filed Sep 28, 2021
Insider Transaction Report
Form 4
Genprex, Inc.GNPX
Berger Mark Stanley
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-09-27+550,000→ 550,000 totalExercise: $2.85From: 2022-09-27Exp: 2031-09-27→ Common Stock (550,000 underlying)
Footnotes (2)
- [F1]The options were granted outside of the Registrant's incentive award plans as an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4).
- [F2]One-third of the options will vest on each of the first, second and third anniversaries of the date on which the Reporting Person commences employment with the Registrant.